• Erick J Martínez-Rodríguez, Juan Gutiérrez-Mejía, Camilo Ríos-Castañeda, Sonia Rojas-Maya, and Adrián Soto-Mota.
• Department of Hospital Reaction for Disasters, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán".
• Gac Med Mex. 2022 Jan 1; 158 (1): 313531-35.

IntroductionOne of the functions of vitamin D is to regulate respiratory epithelium inflammatory response; therefore, deficiency of this vitamin in the context of COVID-19 could constitute a predictive biomarker of the disease outcome.ObjectiveTo evaluate the usefulness of vitamin D for predicting mortality in patients with COVID-19.MethodsObservational, retrospective study in which 154 patients diagnosed with COVID-19 were included, out of whom 111 survived and 43 died. Vitamin D concentration was determined in all of them.ResultsA log-rank p-value < 0.032 was obtained for survival when vitamin D concentration was used as a categorical variable (≤ 20 ng/mL and > 20 ng/mL). On Cox proportional analysis, age and vitamin D concentration were shown to be risk factors associated with mortality in patients with COVID-19 (age: HR = 1.036, 95% CI = 1.016-1.058, p < 0.001; vitamin D: HR (≤ 20 ng/mL and > 20 ng/mL) = 0.478, 95% CI = 0.237-0.966, p < 0.040).ConclusionAge and vitamin D concentration were predictive factors for mortality in COVID-19-infected patients.Copyright: © 2022 Permanyer.

14 keywords...

hide…